The U. Nottingham spinoff company NeuPulse writes, “The clinical trial investigating the effects of median nerve stimulation on Tourette syndrome and associated symptoms has completed recruitment and all participants are now in the ‘follow-up period’, in which participants health is monitored for 6 months. The results from the trial will be published in 2023.”
such an exciting update! my son was a participant in your lab’s Median nerve stimulation clinic trial in March-April of 2022. When will the new wearable device be available in US? We are looking forward to purchase one asap.
It’s not clear to me how readily these could be made available in the U.S. But watch tics.wustl.edu for news.